PCR identification of Mycobacterium bovis BCG

Journal of Clinical Microbiology

Volumn 35, Issue 3, 1997, Pages 566-569

  Talbot, Elizabeth A ^a   Williams, Diana L ^b   Frothingham, Richard ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BCG VACCINE;

ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; MYCOBACTERIUM BOVIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 0031052975     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.3.566-569.1997     Document Type: Article

References (33)

1. Abou-Zeid, C., I. Smith, J. M. Grange, J. Steele, and G. A. W. Rook. 1986. Subdivision of daughter strains of bacille Calmette Guerin (BCG) according to secreted protein patterns. J. Gen. Microbiol. 132:3047-3052.
2. American Type Culture Collection. 1992. Catalogue of bacteria and bacteriophages, 18th ed. American Type Culture Collection, Rockville, Md.
3. Brosman, S. A. 1992. Bacillus Calmette-Guerin immunotherapy. Urol. Clin. North Am. 19:557-564.
4. Cave, M. D., K. D. Eisenach, P. F. McDermott, J. H. Bates, and J. T. Crawford. 1991. IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting. Mol. Cell. Probes 5:73-80.
5. Cave, M. D., K. D. Eisenach, M. Salfinger, J. H. Bates, and J. T. Crawford. 1992. Usefulness of IS6110 in fingerprinting DNA of Mycobacterium bovis. Med. Microbiol. Lett. 1:96-102.
6. Dankner, W. M., N. J. Waeker, M. A. Essey, K. Moser, M. Thompson, and C. E. Davis. 1993. Mycobacterium bovis infections in San Diego: a clinico-epidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine 72:11-37.
7. Edwards, K. M., and D. S. Kernodle. 1996. Possible hazards of routine bacillus Calmette-Guerin immunization in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 15:836-838.
8. Floyd, M. M., V. A. Silcox, W. D. Jones, Jr., W. R. Butler, and J. O. Kilburn. 1992. Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J. Clin. Microbiol. 30:1327-1330.
9. Fomukong, N. G., J. W. Dale, T. W. Osborn, and J. M. Grange. 1992. Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J. Appl. Bacteriol. 72:126-133.
10. Frothingham, R. 1995. Differentiation of strains in Mycobacterium tuberculosis complex by DNA sequence polymorphisms, including rapid identification of M. bovis BCG. J. Clin. Microbiol. 33:840-844.
11. Frothingham, R., and K. H. Wilson. 1994. Molecular phylogeny of the Mycobacterium avium complex demonstrates clinically meaningful divisions. J. Infect. Dis. 169:305-312.
12. Jones, W. D., Jr. 1975. Differentiation of known strains of BCG from isolates of Mycobacterium bovis and Mycobacterium tuberculosis hy using mycobacteriophage 33D. J. Clin. Microbiol. 1:391-392.
13. Kristjansson, M., P. Green, H. L. Manning, A. M. Slutsky, S. M. Brecher, C. F. von Reyn, R. D. Arbeit, and J. N. Maslow. 1993. Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation. Clin. Infect. Dis. 17:228-230.
14. Kumar, D., B. S. Srivastava, N. B. Singh, and R. Srivastava. 1996. Identification of a 25-kilodalton protein of Mycobacterium bovis BCG to distinguish BCG strains from Mycobacterium tuberculosis. J. Clin. Microbiol. 34:224-226.
15. Lamm, D. L. 1992. Complications of bacillus Calmette-Guerin immunotherapy. Urol. Clin. North Am. 19:565-572.
16. Lamm, D. L., A. P. N. van der Meijden, A. Morales, et al. 1992. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol. 147:596-600.
17. Liébana, E., A., Aranaz, B. Francis, and D. Cousins. 1996. Assessment of genetic markers for species differentiation within the Mycobacterium tuberculosis complex. J. Clin. Microbiol. 34:933-938.
18. Lotte, A., O. Wasz-Hockert, and N. Poisson. 1988. Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull. Int. Union Tuberc. 63:47-59.
19. Lotte, A., O. Wasz-Hockert, N. Poisson, N. Dumitrescu, M. Verron, and E. Couvet. 1984. BCG complications: estimates for the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv. Tuberc. Res. 21:107-193.
20. Lugosi, L. 1992. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guerin to molecular biology. A review. Tubercle Lung Dis. 73:252-261.
21. Mahairas, G. G., P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover. 1996. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178:1274-1282.
22. National Institutes of Health. 1980. Mycobacterial culture collection. NIH Publication No 80-289. National Institutes of Health, Bethesda, Md.
23. Parra, C. A., L. P. Londoño, P. Del Portillo, and M. E. Patarroyo. 1991. Isolation, characterization, and molecular cloning of a specific Mycobacterium tuberculosis antigen gene: identification of a species-specific sequence. Infect. Immun. 59:3411-3417.
24. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
25. Sreevatsan S., P. Escalante, X. Pan, D. A. Gillies II, S. Siddiqui, C. N. Khalaf, B. N. Kreiswirth, P. Bifani, L. G. Adams, T. Ficht, V. S. Perumaalla, M. D. Cave, J. D. A. van Embden, and J. M. Musser. 1996. Identification of a polymorphic nucleotide in oxyR specific for Mycobacterium bovis. J. Clin. Microbiol. 34:2007-2010.
26. Stone, M. M., A. M. Vannier, S. K. Storch, C. Peterson, A. T. Nitta, and Y. Zhang. 1995. Brief report: meningitis due to iatrogenic BCG infection in two immunocompromised children. N. Engl. J. Med. 333:561-563.
27. Talbot, E. A. S., M. D. Perkins, S. F. M. Silva, and R. Frothingham. Disseminated BCG disease after vaccination: case report and review of the literature Clin. Infect. Dis., in press.
28. van Soolingen, D., P. W. M. Hermans, P. E. W. de Haas, and J. D. A. van Embden. 1992. Insertion element IS1081-associated restriction fragment length polymorphisms in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG. J. Clin. Microbiol. 30:1772-1777.
29. Wayne, L. G. 1982. Microbiology of tubercle bacilli. Am. Rev. Respir. Dis. 125(Suppl.):31-41.
30. Wayne, L. G., and G. P. Kubica. 1986. The mycobacteria, p. 1435-1457. In P. H. A. Sneath and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 2. Williams & Wilkins, Baltimore, Md.
31. Williams, D. L., T. P. Gillis, and W. G. Dupree. 1995. Ethanol fixation of sputum sediments for DNA-based detection of Mycobacterium tuberculosis. J. Clin. Microbiol. 33:1558-1561.
32. Williams, D. L., C. Waguespack, K. Eisenach, J. T. Crawford, F. Portaels, M. Salfinger, C. M. Nolan, C. Abe, V. Sticht-Groh, and T. P. Gillis. 1994. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
33. Zhang, Y., R. J. Wallace, Jr., and G. H. Mazurek. 1995. Genetic differences between BCG substrains. Tubercle Lung Dis. 76:43-50.